Rovia Clinical Research Announces Acquisitions of Pinnacle Research Group and Cullman Clinical Trials in Alabama

September 15, 2026

Rovia Clinical Research Announces Acquisitions of Pinnacle Research Group and Cullman Clinical Trials in Alabama

Rovia Clinical Research Announces Acquisitions of Pinnacle Research Group and Cullman Clinical Trials in Alabama

Southlake, TX: September 15^th, 2026 - Rovia Clinical Research ("Rovia") is excited to welcome two dedicated clinical research sites - Pinnacle Research Group ("Pinnacle") in Anniston, Alabama, and Cullman Clinical Trials ("CCT") in Cullman, Alabama - to its growing network of clinical research sites. Pinnacle's co-founders, Tracy M. Sims, CCRC, and Darin K. Sims, MBA, bring over 35 years of clinical research experience to Rovia and enhance Rovia's capabilities in cardiometabolic health, obesity, infectious disease, immunology and Phase I research programs. CCT's Managing Partner, Alex Seligson, and his team bring specialized expertise in cardiometabolic, sleep medicine, infectious disease and diagnostics research, all while sharing Rovia's unrelenting commitment to operational excellence and best-in-class quality.

Rovia CEO Patricio Casillas highlighted the strategic importance of the acquisitions, noting, "Tracy, Darin, and Alex, along with their research teams, bring historically consistent and reliable research performance in their underserved communities, across highly complex to lower complexity studies. We are excited for our shared futures and to continue to deliver top-tier results for our life science partners and for the local patient communities."

David Friedman, Partner at Gauge Capital, noted, "We are thrilled to be adding two such high-quality sites to the Rovia network and are excited about the momentum behind Rovia's continued growth."

Rovia Clinical Research is a US-based multi-specialty clinical research site network that partners with healthcare providers, pharmaceutical, biotech, and contract research organizations worldwide. Rovia facilitates clinical trial delivery while providing exceptional service levels, including rapid study start-up speed, enrollment target achievement, strong data quality and unsurpassed patient satisfaction. The company's quality-focused, integrated research services for new drugs, devices, and diagnostic studies are designed to offer improved access and new hope to patients from diverse communities. With 20 locations across 8 states, Rovia aims to continue expanding through acquisitions and strategic partnerships across the United States.

About Rovia

Rovia Clinical Research is a multi-specialty, clinical research site network with 20+ years of research experience. It operates a hub and spoke model of freestanding sites and physician-embedded capabilities. Across its 20 wholly-owned sites, Rovia's core research focus includes endocrinology, obesity, cardiology, gastroenterology, neurology, psychiatry, ophthalmology, and infectious disease. Rovia has a proven history of enrolling patients with outstanding retention, rapid study start-up, and high-quality data. The network is a preferred partner to leading global pharma and biotech customers.

About Gauge Capital

Gauge Capital is a middle-market private equity firm based in Southlake, Texas. Gauge invests in three key sectors: healthcare, business services & technology, and food & consumer. The firm manages more than $3.0 billion in capital. For more information, please contact Chris Garvin, Principal, Business Development at [email protected].